SPOTLIGHT: GAO questions antidotes for pandemic


The GAO says that a pandemic vaccine can offer little help during the crucial initial stages of an outbreak. The Department of Health and Human Services has estimated that it would take 20 to 23 weeks to develop and manufacture a vaccine targeted at a specific strain. And increasing access to antivirals--the second key strategy for dealing with a pandemic--would demand construction of new facilities and fresh sources of production material. FierceVaccines

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.